DMedical (ASX:4DX) has signed a contract with GlaxoSmithKline to supply quantitative lung imaging analytics. The agreement focuses on using 4DMedical’s technology in GSK’s drug development programs.

Jane Street files to dismiss Terraform Labs' $4 billion insider trading lawsuit, calling it a meritless attempt to shift ...

QuantumScape (NYSE:QS | QS Price Prediction), the pre-revenue solid-state battery developer, used its Q4 2025 report to pair ...

Against the backdrop of continued repricing in global capital markets and accelerating technological change, China Industrial ...

Tata Mutual Fund has acquired 33 lakh shares (1.66 percent stake) in Mufin Green Finance for Rs 37.36 crore at Rs 113.23 per ...

JPMorgan’s revenue from quantitative investment strategies for clients is up 30%, making it one of the bank’s fastest-growing ...

Collateral is an asset you can pledge to secure financing. While it can be beneficial and even necessary with some loans, ...

The Mahindra Manulife Value Fund was closely followed by DSP Value Fund, which generated 15.66%, and LIC MF Value Fund, which ...

The competition for talent between Wall Street and Silicon Valley has been building for years. But over the past eighteen ...

International developed market stocks have beaten the S&P 500 by a wide margin year to date, and one Fidelity ETF is quietly ...

Agreed during the deposed Awami League government, the IMF’s $5.5 billion loan programme continued through the interim administration and into the tenure of the new BNP government ...

Benjamin Cowen explains why the 2025 altcoin season never materialized — and why topping on apathy rather than euphoria made ...